OpenURL Connection Search

Select item for more details and to access through your institution.

Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?
Published in:
2012
By:
- De Ruysscher D;
- Van Meerbeeck J;
- Vandecasteele K;
- Oberije C;
- Pijls M;
- Dingemans AM;
- Reymen B;
- van Baardwijk A;
- Wanders R;
- Lammering G;
- Lambin P;
- De Neve W;
- De Ruysscher, D;
- Van Meerbeeck, J;
- Vandecasteele, K;
- Oberije, C;
- Pijls, M;
- Dingemans, A M C;
- Reymen, B;
- van Baardwijk, A
Publication type:
journal article
VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
Published in:
2012
By:
- Kuiper JL;
- Lind JS;
- Groen HJ;
- Roder J;
- Grigorieva J;
- Roder H;
- Dingemans AM;
- Smit EF;
- Kuiper, J L;
- Lind, J S W;
- Groen, H J M;
- Roder, J;
- Grigorieva, J;
- Roder, H;
- Dingemans, A M C;
- Smit, E F
Publication type:
journal article
VeriStrat<sup>®</sup> has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.
Published in:
British Journal of Cancer, 2012, v. 107, n. 11, p. 1820, doi. 10.1038/bjc.2012.470
By:
- Kuiper, J L;
- Lind, J S W;
- Groen, H J M;
- Roder, J;
- Grigorieva, J;
- Roder, H;
- Dingemans, A M C;
- Smit, E F
Publication type:
Article
Chemotherapy and Tyrosine Kinase Inhibitors in the last month of life in patients with metastatic lung cancer: A patient file study in the Netherlands.
Published in:
European Journal of Cancer Care, 2020, v. 29, n. 2, p. 1, doi. 10.1111/ecc.13210
By:
- Mieras, Adinda;
- Becker‐Commissaris, Annemarie;
- Pasman, H. Roeline W.;
- Dingemans, Anne‐Marie M. C.;
- Kok, Edith V.;
- Cornelissen, Robin;
- Jacobs, Wouter;
- Berg, Jan Willem;
- Welling, Alle;
- Bogaarts, Brigitte A. H. A.;
- Pronk, Lemke;
- Onwuteaka‐Philipsen, Bregje D.
Publication type:
Article

Found: 4

Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?

VeriStrat(®) has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.

VeriStrat<sup>®</sup> has prognostic value in advanced stage NSCLC patients treated with erlotinib and sorafenib.

Chemotherapy and Tyrosine Kinase Inhibitors in the last month of life in patients with metastatic lung cancer: A patient file study in the Netherlands.